UNSPSC 51101649: Clopidol

This classification denotes an antiprotozoal agent with the molecular formula C7H7Cl2NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8J763HFF5N, chemically known as 3,5-dichloro-4-hydroxy-2,6-dimethylpyridine but generally known as clopidol, which bears US NIH Compound Identifier 18087. European Medicines Agency schedules Clopidol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06739MIG.

UNSPSC 51101649 Clopidol is a Commodity code that, based on recent state and local solicitations, does not reflect the pharmaceutical and medical-supply procurement activity actually being tagged under it. The four recent opportunities posted under this code involve naloxone and drug deactivation systems (Seminole County, Florida), direct-to-manufacturer prescription programs (Texas HHS Commission), fire-rescue medical and first-aid supplies (City of Tampa), and generic multi-source pharmaceuticals and OTC products through cooperative purchasing (Minnesota Multistate Cooperative Purchasing Alliance serving multiple states including Oregon). These solicitations span naloxone procurement for community health, pharmacy benefit program restructuring, emergency-response medical consumables, and wholesale pharmaceutical distribution—none of which align with clopidol, a poultry feed additive. The issuing bodies include county health departments, state HHS agencies, municipal fire departments, and cooperative purchasing alliances serving multiple state and local jurisdictions. Work being solicited is dominated by pharmaceutical and medical-supply purchasing in health-department and emergency-response contexts rather than veterinary or agricultural applications.

The geographic spread of recent activity covers Florida, Texas, Minnesota, and Oregon, with the cooperative purchasing vehicle (MMCAP) spanning multiple jurisdictions across the Upper Midwest and Pacific Northwest. Representative recent opportunities include Seminole County's IFB for 1,900 units of naloxone and 800 drug deactivation systems annually (posted June 30, 2026, due July 26, 2023—note: the due date appears to be a data error in the source), the City of Tampa's IFB for 169 line items of medical and first-aid supplies for the fire department with an estimated contract amount of $700,000.00 (due March 13, 2026, sheltered for certified Small Local Business Enterprises with a 5 percent bid discount), and Minnesota's MMCAP RFP for generic multi-source pharmaceuticals and OTC products with proposals due March 26, 2026. The code appears to carry a data-classification mismatch; firms pursuing pharmaceutical and medical-supply contracts should monitor codes more directly tied to those commodity families rather than rely on this designation.